Frequently Asked Questions

Clovo is an AI-driven prehabilitation and rehabilitation platform designed to support surgical and cancer patients through personalised recovery programmes. Clovo delivers clinically designed guidance across movement, nutrition, mindset and recovery, scaled to any number of patients simultaneously through its AI recovery coach, Amy.

Clovo assesses each patient at baseline and builds a personalised recovery plan across five stages: assessment, adaptive prehab, surgical event or treatment, adaptive recovery, and outcomes and transition. Amy, Clovo's AI recovery coach, delivers day-by-day guidance through a mobile application, adapting plans in real time based on patient progress, adherence, and reported wellbeing.

Traditional prehabilitation reaches fewer than 10% of patients who would benefit, largely due to staffing constraints and geographic limitations. Clovo removes both barriers by delivering clinician-designed prehab and rehab digitally, at scale, with full personalisation for each patient. Where a traditional programme serves dozens of patients per clinician, Clovo serves thousands without compromising the quality or continuity of care.

Clovo is designed to support patients across surgical and oncology pathways where prehabilitation and structured recovery have demonstrated clinical benefit. Current deployments and validation work span general surgery, orthopaedics, and cancer care, with pathway coverage expanding in line with clinical evidence and partner requirements.

Prehabilitation is supported by a growing body of peer-reviewed clinical evidence demonstrating meaningful improvements in surgical outcomes. Studies across surgical and oncology pathways have shown that structured prehab reduces post-surgical complications by up to 64%, cuts average hospital stays by four days, and doubles functional recovery at 30 days post-operation. Clovo's programmes are designed and delivered in line with this evidence base, with all clinical content developed alongside experienced practitioners in physiotherapy, nutrition, and psychology.

Clovo tracks engagement, adherence, functional recovery signals, and patient-reported outcomes across the full surgical pathway, from baseline assessment through to post-operative transition. Data is captured continuously through the platform and surfaced to partner organisations through outcome reports, supporting both individual patient oversight and broader service evaluation.

Clovo is designed as an evidence-generating platform, not just a care delivery tool. Every patient interaction produces structured, auditable data that can be used to evaluate programme effectiveness, support research publications, and build the clinical evidence base for AI-driven prehabilitation at scale. Partners working with Clovo have the opportunity to co-author findings and contribute to the growing body of digital health evidence in surgical and oncology care.

Clovo has undertaken validation work with NHS Forth Valley and the Digital Health Validation Lab at the University of Glasgow, with further validation activity ongoing. These partnerships provide independent clinical oversight of Clovo's programmes, safety architecture, and outcome methodologies, ensuring that the platform meets the standards required for deployment within NHS and equivalent healthcare systems.

Clovo provides partner organisations with structured outcome data and engagement metrics that support ongoing service evaluation and pathway optimisation. Reports can be configured to align with existing quality improvement frameworks, giving clinical and operational teams the evidence they need to assess programme impact, demonstrate value to commissioners, and make informed decisions about pathway design.

Partner organisations receive access to aggregated and individual-level data covering patient engagement, adherence rates, recovery signals, and outcome measures across their patient cohort. All data is provided in line with applicable data protection legislation and governance frameworks agreed at the outset of each partnership. Clovo does not share patient data beyond the scope of the agreed partnership without explicit consent.

Clovo is built with rule-based safety layers that govern every patient interaction, ensuring that guidance remains within clinically appropriate boundaries at all times. The platform's AI operates within parameters defined and validated by experienced clinicians across physiotherapy, nutrition, and psychology. Where patient-reported data indicates a potential concern, Clovo's escalation pathways automatically flag the case for clinical review, ensuring that no patient in distress goes unnoticed.

Clovo monitors patient-reported wellbeing, adherence, and recovery signals continuously throughout the programme. Where responses fall outside safe thresholds, the platform triggers escalation protocols that notify the relevant clinical team within the partner organisation. Escalation pathways are configured at the outset of each partnership to align with the clinical governance structures already in place, ensuring Clovo integrates into rather than disrupts existing oversight processes.

Clovo is developed in alignment with UK regulatory frameworks for AI-driven digital health tools, including UKCA Software as a Medical Device fast-track pathways. Clovo's development roadmap includes formal SaMD certification as the platform scales, with current deployments operating under validated pilot frameworks agreed with partner organisations and supported by independent clinical oversight.

Clovo handles all patient data in accordance with UK GDPR and applicable data protection legislation. Patient data is stored securely, processed only for the purposes agreed within each partnership, and never shared beyond the scope of that agreement without explicit consent. Data governance frameworks are established at the outset of each partnership, giving partner organisations full visibility and control over how their patient data is managed within the platform.

Clovo's clinical programmes and safety architecture are developed and reviewed by an experienced multidisciplinary team spanning physiotherapy, nutrition, and psychology. Independent clinical oversight is provided through Clovo's validation partnerships, including NHS Forth Valley and the Digital Health Validation Lab at the University of Glasgow. Partner organisations retain clinical responsibility for their patient cohorts, with Clovo operating as a digitally delivered extension of the care pathway rather than a replacement for clinical judgement.

Clovo maintains comprehensive audit trails across all patient interactions, programme adaptations, and escalation events. These records are available to partner organisations to support clinical governance, quality assurance, and regulatory compliance requirements. Audit data is structured to align with the reporting needs of NHS and equivalent healthcare systems, ensuring that Clovo deployments can be reviewed and evaluated to the standards required by commissioners and oversight bodies.

Clovo is designed to be deployed rapidly within existing clinical pathways, with most partner organisations operational within four to eight weeks of agreement. The implementation process covers pathway configuration, escalation protocol setup, staff orientation, and patient onboarding workflow design. Clovo's implementation team works directly with clinical and operational leads at each partner organisation to ensure the platform is configured to the specific needs of their service before go-live.

Clovo is built with integration capability in mind, supporting data exchange with existing electronic health record and patient management systems used across NHS and equivalent healthcare environments. Integration requirements are scoped during the implementation process, with Clovo's technical team working alongside partner IT and informatics teams to establish secure, compliant data flows. Where full integration is not immediately feasible, Clovo operates effectively as a standalone platform with manual patient onboarding workflows.

Patients are onboarded to Clovo through a straightforward digital registration process, accessible via smartphone. Following registration, Clovo conducts a baseline assessment covering physical function, nutritional status, psychological wellbeing, and health literacy, which forms the foundation of each patient's personalised programme. The onboarding process is designed to be completed independently by patients, minimising the administrative burden on clinical teams while ensuring every patient starts with a programme calibrated to their individual needs.

Clovo is designed to integrate into existing workflows with minimal disruption to clinical teams. Staff orientation typically covers platform navigation, patient monitoring, escalation response procedures, and outcome reporting, and can be completed in a single session. Ongoing support is provided by Clovo's implementation team throughout the partnership, with documentation and training materials available on demand to accommodate staff changes and service development.

Clovo is a cloud-based platform accessible via standard web browsers for clinical and operational teams, with a native mobile application for patients available on iOS and Android. There are no specialist hardware requirements for deployment. Network and information governance requirements are assessed during the implementation process to ensure Clovo meets the technical and security standards of each partner organisation, including NHS Digital Security Protection Toolkit alignment where applicable.

Clovo operates on a partnership basis, with commercial models structured to reflect the scale, pathway scope, and deployment context of each partner organisation. Pricing is discussed directly with prospective partners during the evaluation process, with arrangements available to suit NHS providers, private healthcare operators, and insurance organisations. To discuss commercial terms relevant to your organisation, please get in touch with the Clovo team directly.

Clinical evidence demonstrates that structured prehabilitation reduces post-surgical complications by up to 64% and cuts average hospital stays by four days, representing significant cost reductions for insurers managing surgical claims. Clovo delivers these outcomes at scale and at a fraction of the cost of traditional prehab delivery, making the commercial case compelling for insurers seeking to reduce claims costs while improving member outcomes. Clovo works with insurer partners to model expected ROI based on their specific member population and surgical volume.

Clovo is designed to align directly with value-based care frameworks by tying programme delivery to measurable patient outcomes rather than activity volume. The platform generates continuous outcome data across engagement, functional recovery, and patient-reported measures, giving insurers and providers the evidence needed to demonstrate value to commissioners and inform outcome-based contracting arrangements. As healthcare systems shift toward paying for outcomes rather than appointments, Clovo provides the infrastructure to support that transition.

Clovo provides insurer partners with structured reporting covering member engagement, programme adherence, recovery outcomes, and escalation activity across their covered population. Reports are configurable to align with existing actuarial and claims management frameworks, and can be delivered at agreed intervals or accessed on demand through the partner dashboard. All reporting is provided in line with applicable data protection requirements, with member-level data accessible only where appropriate consent and governance frameworks are in place.

Clovo reduces claims costs by improving patient readiness for surgery and supporting faster, more complete recovery post-operatively, directly addressing the two points in the surgical pathway where complications and extended stays most commonly drive claim value. By delivering structured prehabilitation and rehabilitation digitally, Clovo makes evidence-based interventions accessible to significantly more members than traditional delivery models allow, increasing the proportion of the insured population that benefits from prehab and amplifying the aggregate cost reduction across the claims book.

Clovo actively seeks research and innovation partnerships with academic institutions, NHS trusts, and digital health organisations that share a commitment to improving surgical and oncology outcomes at scale. Research partnerships are structured to reflect the goals and timelines of each collaborating organisation, with Clovo contributing platform access, patient interaction data, and technical expertise in exchange for independent clinical validation, academic oversight, and co-authorship of findings. Prospective research partners are encouraged to get in touch early in their project planning process to explore what a collaboration with Clovo could look like.

Clovo generates structured, longitudinal data across patient engagement, adherence, functional recovery signals, and patient-reported outcomes throughout the prehab and rehab pathway. This data is available to research partners under appropriate governance frameworks, including data sharing agreements, ethical approvals, and information governance protocols agreed in advance of any research activity. All data shared for research purposes is anonymised or pseudonymised in line with UK GDPR and applicable research ethics requirements.

Clovo welcomes co-development partnerships with organisations seeking to extend the platform's capability, validate new clinical pathways, or integrate Clovo into broader digital health ecosystems. Co-development arrangements are scoped on a case-by-case basis, with intellectual property, funding, and publication rights agreed transparently at the outset. Organisations interested in co-development are invited to contact the Clovo team to discuss how a partnership could be structured to meet their specific objectives.

Clovo currently works with NHS Forth Valley, the Digital Health Validation Lab at the University of Glasgow, and the West of Scotland Innovation Hub, alongside support from Scottish Enterprise, Scottish EDGE, and Microsoft for Startups. These partnerships provide Clovo with independent clinical validation, access to real-world deployment environments, and the infrastructure to scale evidence generation across surgical and oncology pathways. Clovo is actively expanding its network of research and innovation partners and welcomes enquiries from organisations working in aligned areas.